BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

681 related articles for article (PubMed ID: 24565034)

  • 1. Identification of mutated core cancer modules by integrating somatic mutation, copy number variation, and gene expression data.
    Zhang J; Zhang S; Wang Y; Zhang XS
    BMC Syst Biol; 2013; 7 Suppl 2(Suppl 2):S4. PubMed ID: 24565034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying mutated driver pathways in cancer by integrating multi-omics data.
    Wu J; Cai Q; Wang J; Liao Y
    Comput Biol Chem; 2019 Jun; 80():159-167. PubMed ID: 30959272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An integrative characterization of recurrent molecular aberrations in glioblastoma genomes.
    Sintupisut N; Liu PL; Yeang CH
    Nucleic Acids Res; 2013 Oct; 41(19):8803-21. PubMed ID: 23907387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying overlapping mutated driver pathways by constructing gene networks in cancer.
    Wu H; Gao L; Li F; Song F; Yang X; Kasabov N
    BMC Bioinformatics; 2015; 16 Suppl 5(Suppl 5):S3. PubMed ID: 25859819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Method for Identifying the Potential Cancer Driver Genes Based on Molecular Data Integration.
    Zhang W; Wang SL
    Biochem Genet; 2020 Feb; 58(1):16-39. PubMed ID: 31115714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating Protein-Protein Interaction Networks and Somatic Mutation Data to Detect Driver Modules in Pan-Cancer.
    Wu H; Chen Z; Wu Y; Zhang H; Liu Q
    Interdiscip Sci; 2022 Mar; 14(1):151-167. PubMed ID: 34491536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated network analysis identifies core pathways in glioblastoma.
    Cerami E; Demir E; Schultz N; Taylor BS; Sander C
    PLoS One; 2010 Feb; 5(2):e8918. PubMed ID: 20169195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of driver pathways in cancer based on combinatorial patterns of somatic gene mutations.
    Li HT; Zhang J; Xia J; Zheng CH
    Neoplasma; 2016; 63(1):57-63. PubMed ID: 26639234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutual exclusivity analysis identifies oncogenic network modules.
    Ciriello G; Cerami E; Sander C; Schultz N
    Genome Res; 2012 Feb; 22(2):398-406. PubMed ID: 21908773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of ovarian cancer subtype-specific network modules and candidate drivers through an integrative genomics approach.
    Zhang D; Chen P; Zheng CH; Xia J
    Oncotarget; 2016 Jan; 7(4):4298-309. PubMed ID: 26735889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network analysis of genomic alteration profiles reveals co-altered functional modules and driver genes for glioblastoma.
    Gu Y; Wang H; Qin Y; Zhang Y; Zhao W; Qi L; Zhang Y; Wang C; Guo Z
    Mol Biosyst; 2013 Mar; 9(3):467-77. PubMed ID: 23344900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Integrated Analyses of Driver Genes Identify Key Biomarkers in Thyroid Cancer.
    Xu Q; Song A; Xie Q
    Technol Cancer Res Treat; 2020; 19():1533033820940440. PubMed ID: 32812852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of mutated subnetworks associated with clinical data in cancer.
    Vandin F; Clay P; Upfal E; Raphael BJ
    Pac Symp Biocomput; 2012; ():55-66. PubMed ID: 22174262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo discovery of mutated driver pathways in cancer.
    Vandin F; Upfal E; Raphael BJ
    Genome Res; 2012 Feb; 22(2):375-85. PubMed ID: 21653252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BeWith: A Between-Within method to discover relationships between cancer modules via integrated analysis of mutual exclusivity, co-occurrence and functional interactions.
    Dao P; Kim YA; Wojtowicz D; Madan S; Sharan R; Przytycka TM
    PLoS Comput Biol; 2017 Oct; 13(10):e1005695. PubMed ID: 29023534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous Integration of Multi-omics Data Improves the Identification of Cancer Driver Modules.
    Silverbush D; Cristea S; Yanovich-Arad G; Geiger T; Beerenwinkel N; Sharan R
    Cell Syst; 2019 May; 8(5):456-466.e5. PubMed ID: 31103572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinguishing between driver and passenger mutations in individual cancer genomes by network enrichment analysis.
    Merid SK; Goranskaya D; Alexeyenko A
    BMC Bioinformatics; 2014 Sep; 15(1):308. PubMed ID: 25236784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Driver Modules with Rarely Mutated Genes in Cancers.
    Li F; Gao L; Wang B
    IEEE/ACM Trans Comput Biol Bioinform; 2020; 17(2):390-401. PubMed ID: 29994261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voting-based cancer module identification by combining topological and data-driven properties.
    Azad AK; Lee H
    PLoS One; 2013; 8(8):e70498. PubMed ID: 23940583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis.
    Li A; Chapuy B; Varelas X; Sebastiani P; Monti S
    Sci Rep; 2019 Nov; 9(1):16904. PubMed ID: 31729402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.